Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,322 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06671262RecruitingPhase 2
Immunotherapy plus radiation before breast cancer surgery
This trial tests combining two treatments—an immunotherapy drug (Toripalimab) and radiation—before surgery for a certain type of breast cancer (HR+, HER2-negative) that has spread to lymph nodes. The goal is to see if this combination helps shrink the tumor more than standard therapy alone.
Hangzhou, ZhejiangAges 18–85 - NCT06819410Recruiting
Comparing antifungal treatments for invasive fungal disease
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
Chengdu, SichuanAges Any age - NCT06819774RecruitingPhase 3
Testing cetirizine injection for acute hives
This trial tests an injectable medication (cetirizine, a type of antihistamine) to see if it quickly relieves itching and hives in adults with acute (short-term) hives. It is for people whose hives have lasted less than 6 weeks and who still have bothersome symptoms.
Beijing, Beijing MunicipalityAges 18–65 - NCT04103567Recruiting
Testing stool and bacteria clues for poor rectal cancer response
This study looks at stool samples to see whether gut bacteria or other microbes help explain why some rectal cancers respond less well to treatment given before surgery. If you have mid or lower rectal cancer and are planning pre-surgery treatment, your information and stool sample may help researchers improve how treatment is chosen.
Montpellier, HéraultAges 18 years+ - NCT03999983Recruiting
Procedure registry for blocked vertebral artery origins
This trial registry collects information on patients treated with a catheter-based procedure for narrowed or blocked vertebral artery openings in the back of the brain. It may help doctors better understand which patients benefit and how treatment is done, but it’s mainly about tracking outcomes and safety.
Jacksonville, FloridaAges 18–90 - NCT04686877Recruiting
Surgery to remove deep brain bleeding with urokinase
This trial tests whether a targeted (stereotactic) procedure to remove deep brain bleeding, combined with a medicine called urokinase, is safer and works better than standard care. It focuses on people whose bleeding is in the deep brain and who are able to undergo surgery within a specific time window.
Fuzhou, FujianAges 40 years+ - NCT05540288RecruitingPhase 3
Nalmefene vs placebo to reduce cravings in behavioral addictions
This study tests whether nalmefene, a non-opioid medicine, can reduce craving episodes in people with behavioral addictions like gambling, food addiction, or sexual addiction. Participants keep tracking cravings weekly, and compare the nalmefene effect against a placebo in addition to their usual care.
BesançonAges 18 years+ - NCT06051760RecruitingPhase 1
NV-001 for advanced solid tumors after standard treatments
This trial tests a new drug called NV-001 for people with advanced solid tumors that are no longer responding to standard treatments. It aims to see if the drug is safe and can help shrink or slow tumor growth.
Beijing, Beijing MunicipalityAges 18–75 - NCT06183645Recruiting
Predicting CIDP decline during IVIg treatment changes
This study looks at people with CIDP who are stable on IVIg treatment to see if we can predict when they might get worse if their treatment is adjusted. It aims to make treatment management easier and more personalized.
Liège, LiègeAges 18–99 - NCT06144762Recruiting
Precision imaging for early detection and treatment monitoring in pancreatic cancer
This trial uses advanced imaging to detect pancreatic cancer early and track how well treatment is working. It may help if you have pancreatic cancer that can be surgically removed, either right away or after chemotherapy.
MontpellierAges 18 years+ - NCT07407738Recruiting
A trial of a shockwave device for calcified heart arteries
This trial tests a new device that uses sound waves to break up calcium deposits in heart arteries before placing a stent. It is for people with severely hardened arteries that are hard to treat with standard methods.
LyonAges 18 years+ - NCT07415863RecruitingPhase 1/Phase 2
Study of SYS6043 for advanced solid tumors
This trial tests a new drug, SYS6043, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can help shrink or control the tumor.
Beijing, Beijing MunicipalityAges 18–75 - NCT07413978RecruitingPhase 1/Phase 2
Stem cell injection for severe ARDS
This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).
Wuhan, HubeiAges 18–80 - NCT07412860Recruiting
Eye drop test for moderate to severe dry eye
This trial tests a new eye drop (FBV_01) compared to a standard hyaluronic acid eye drop for people with moderate to severe dry eye. The goal is to see if the new drop provides better relief.
Cagliari, CAAges 18 years+ - NCT07409090Enrolling by invitation
Micro-Coring for loose skin on the knees
This trial tests a new, minimally invasive tool called Micro-Coring to tighten loose skin on the knees. It may be a good option if you have mild to moderate skin looseness on your knees and are looking for a non-surgical fix.
Sacramento, CaliforniaAges 22–70 - NCT07415031RecruitingPhase 2
Long term treatment with adagrasib for solid tumor patients
This trial allows people with solid tumors who are already benefiting from the study drug adagrasib in an earlier Mirati study to continue getting it for the long term. It’s for people whose doctors see ongoing benefit and who still meet the safety rules.
Phoenix, ArizonaAges 18 years+ - NCT07413094RecruitingPhase 2
Testing a new drug for sepsis-related lung injury
This trial tests a new medicine called YD0743 for people who have both sepsis (a serious infection) and ARDS (a severe lung injury from the infection). The goal is to see if the medicine helps improve breathing and survival.
BeijingAges 18–75 - NCT07414342Recruiting
Study of RENATUS® valve for severe aortic stenosis
This study tests a new device called the RENATUS® Transcatheter Aortic Valve System for people with severe aortic stenosis. It is designed to replace the narrowed valve without open-heart surgery, and aims to see if it is safe and effective for patients with various surgical risk levels.
BeijingAges 60–100 - NCT07410169RecruitingPhase 2/Phase 3
Oxygen therapy for chemo-related nerve pain in breast cancer
This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can reduce nerve pain caused by the chemotherapy drug nab-paclitaxel in breast cancer patients. It may help women who have finished chemo and are still dealing with numbness, tingling, or pain in their hands or feet.
Guangzhou, GuangdongAges 18–75 - NCT07413354RecruitingPhase 2
Tislelizumab and huaier granule for advanced liver cancer
This trial tests a combination of two drugs: tislelizumab (an immunotherapy that helps your immune system attack cancer) and huaier granule (a traditional Chinese medicine extract). It is for people with advanced liver cancer that cannot be removed by surgery and who have not had other systemic treatments before.
Wuhan, HubeiAges 18 years+ - NCT07416227Recruiting
Comparing two treatments for enlarged prostate
This trial compares two minimally invasive procedures for an enlarged prostate (benign prostatic hyperplasia). It tests whether water vapor thermal therapy or prostatic artery embolization works better to improve urinary symptoms.
Cairo, AbbassiaAges 50 years+ - NCT07411118Recruiting
Comparing two ways to remove stomach GIST tumors with an endoscope
This trial compares two endoscopic techniques (EFTR and STER) for removing small to medium-sized GIST tumors from the stomach wall. It aims to see which method is safer and more effective.
ShanghaiAges 18–75 - NCT07409805RecruitingPhase 1
Vaccine trial for advanced colorectal cancer with liver spread
This trial tests a new vaccine (YMN-136) for people with colorectal cancer that has spread to the liver and hasn't responded to at least three prior treatments. The goal is to see if the vaccine can help control the cancer.
Chengdu, SichuanAges 18–75 - NCT07409831Recruiting
Incretin drugs, diet, and exercise for weight loss
This trial tests whether combining a new type of weight-loss medication with nutrition advice and physical activity helps people with obesity lose more weight. It’s for adults who are about to start an incretin-based drug for the first time.
Québec, QuebecAges 18–70
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,322 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.